Cappy,

You and I have been here a long time, and have acknowledged mutual respect, despite our obvious disagreement on a number of things. With that in mind, I hope you will allow me to challenge you on some of the content of your post to Mark.

1) I don't know why, but it is not uncommon to question the motives of someone who disagrees with us, or somehow sees things differently. I do it myself.

In the case of Mark, I can assure you that it is "business" and not "personal". I have known Mark for several years, (was first introduced over lunch with doc3b) and know the level of his investment and the extent of his due diligence. He just sees things differently than you and Jeff, as do I.

2) I do not give much consideration to personal or professional challenges when investing my money. I do not want to sound callous or crass, but, life is difficult. I have respect for the way Paul Metzinger has handled some of his business challenges (I don't know much about his personal life) as I respect others who do not waver from their vision, despite life's challenges. That's just my perspective. I know you disagree.

3) I don't think I've been "taken". SO, please don't feel sorry for me. I am in this stock with my eyes open, and continue to be very bullish. The things that are happening with Exypnotech tell me that we will continue to see growth each quarter, and that Paul was right all along about NCS being cutting edge. In my opinion, we were just way ahead of market acceptance. We are beginning to see acceptance now.

I believe, based on industry news that I am reading, that we are a very close to market acceptance of Agrastim, as well. I don't have to "muster up hope that there will be a sunny tomorrow." I have confidence in the due diligence I have done, and believe we are not far from seeing growing revenues from both Bioagra and Exypnotech.

4) When I read your reason for not selling this stock and moving on, I wonder at the math. Perhaps you are using a full service broker that charges you a lot of money for a trade. If you are, like many of us, using a discount online broker, fees are usually between $4.99 to $19.99 per trade. Even at $19.99, the sale of 67 shares would cover the cost of the trade. If you have fewer than 67 shares of VYTC and yet continue to invest your time here, It would SEEM, (notice my choice of the word seem) to me that your perspective is a lot more influence by subjectivity than you are willing to admit. Are you hoping for the total demise of the Company, or do you, on the other hand, continue to hold on, hoping to ultimately be proven wrong about the stock, but more importantly, about having been taken?

5) About the chart. It is as objective as it gets. On that we agree. However, when the chart reverses and the share price begins to appreciate, have you given any thought as to whether you would change your opinion and increase your position?

Just curious.

Best regards, despite our disagreement,

-z